Document Detail


Recovery and amplification of placental RNA from dried maternal blood spots: utility for non-invasive prenatal diagnosis.
MedLine Citation:
PMID:  17007679     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Methods utilizing circulating cell-free RNA in plasma have clinical applications for cancer and prenatal genetic analysis. Given these potential roles, the feasibility of detecting placental specific RNA in dried maternal blood spots after storage at room temperature for varying lengths of time was investigated. Using real-time polymerase chain reaction (PCR), positive amplification of placental-specific beta-human chorionic gonadotrophin transcripts was demonstrated in nine of 11 dried blood samples from first and second trimester pregnancies stored at room temperature for up to 4 weeks. This work demonstrates feasibility in isolation and amplification of placental mRNA using dried maternal blood spots. With the development of fetal and placental RNA markers, this approach would allow simplified collection, transport, and storage of samples for prenatal genetic diagnosis and pregnancy related complications.
Authors:
Carolina J Jorgez; Joe Leigh Simpson; Farideh Z Bischoff
Related Documents :
16226119 - Animal models of placental angiogenesis.
19948659 - Adaptations in placental phenotype support fetal growth during undernutrition of pregna...
8547169 - Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension.
20400649 - Distribution of bupivacaine enantiomers and lidocaine and its metabolite in the placent...
12513889 - Placental transfer of cotinine at 12-17 weeks of gestation and at term in heavy smokers.
18928989 - Can placental pathology explain second-trimester pregnancy loss and subsequent pregnanc...
19960239 - Does first polar body morphology predict oocyte performance during icsi treatment?
16536149 - Pregnancy tumor occurring twice in the same individual: report of a case and hormone re...
17154189 - False positives in the prenatal ultrasound screening of fetal structural anomalies.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Reproductive biomedicine online     Volume:  13     ISSN:  1472-6483     ISO Abbreviation:  Reprod. Biomed. Online     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-09-29     Completed Date:  2006-11-01     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  101122473     Medline TA:  Reprod Biomed Online     Country:  England    
Other Details:
Languages:  eng     Pagination:  558-61     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chorionic Gonadotropin, beta Subunit, Human / blood,  genetics
Female
Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) / genetics
Humans
Nucleic Acid Amplification Techniques / methods*
Placenta / physiology*
Pregnancy
Pregnancy Trimester, First
Pregnancy Trimester, Second
Prenatal Diagnosis / methods*
RNA / analysis,  blood*,  isolation & purification*
Grant Support
ID/Acronym/Agency:
HD046623/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Chorionic Gonadotropin, beta Subunit, Human; 63231-63-0/RNA; EC 1.2.1.9/Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+)

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Totipotency, cell differentiation and reprogramming in humans.
Next Document:  Potential clinical applications using stem cells derived from human umbilical cord blood.